ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,413Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 783

$738K Total Retail Price of All Prescriptions

Rank: 77 out of 783

859 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 859 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 5,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $231 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
GABAPENTIN 775 667 1 3
NAMENDA 458 458 2 4
ESCITALOPRAM OXALATE 292 281 3 30
DONEPEZIL HCL 232 232 4 2
EXELON 221 221 5 12
LEVETIRACETAM 206 149 6 5
CARBIDOPA-LEVODOPA 201 190 7 1
VOLTAREN 178 177 8 58
LIDODERM 147 144 9 40
SERTRALINE HCL 142 117 10 26
MIRTAZAPINE 141 139 11 41
CYMBALTA 136 121 12 18
BACLOFEN 125 83 13 17
OMEPRAZOLE 102 45 14 78
BUSPIRONE HCL 101 92 15 75
LIDOCAINE 100 92 16 108
LYRICA 95 95 17 16
PRIMIDONE 90 87 18 13
RIVASTIGMINE 89 89 19 70
AMLODIPINE BESYLATE 87 34 20 51
TRAMADOL HCL 86 39 21 31
PAROXETINE HCL 83 80 22 44
LEXAPRO 78 77 23 59
IBUPROFEN 74 42 24 53
LAMOTRIGINE 73 14 25 9
CITALOPRAM HBR 70 70 26 21
FLECTOR 68 65 27 173
METOPROLOL SUCCINATE 67 49 28 114
ZOLPIDEM TARTRATE 65 48 29 20
SIMVASTATIN 65 58 29 49
ROPINIROLE HCL 64 61 31 10
LEVOTHYROXINE SODIUM 63 29 32 82
METFORMIN HCL 63 41 32 93
LISINOPRIL 59 29 34 112
AMITRIPTYLINE HCL 56 26 R 35 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.